Epic Therapeutics
Gosselies
About Epic Therapeutics
EPICS Therapeutics develop novel therapeutic solutions for cancer, based on the highly innovative field of RNA epigenetics.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $8.4M
- Funding stage: Seed
- Last round: Seed (May 2018)
- Website: epicstherapeutics.com
- Phone: +32 71 348 500
Industries & Categories
Biopharma, Health Care
Social Profiles
Canonical: https://fsome.com/organization/epic-therapeutics-38560 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.